These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 26953239

  • 1. Ursolic Acid Nanocrystals for Dissolution Rate and Bioavailability Enhancement: Influence of Different Particle Size.
    Pi J, Liu Z, Wang H, Gu X, Wang S, Zhang B, Luan H, Zhu Z.
    Curr Drug Deliv; 2016; 13(8):1358-1366. PubMed ID: 26953239
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
    Jain S, Reddy VA, Arora S, Patel K.
    Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
    [Abstract] [Full Text] [Related]

  • 6. Preparation and Evaluation of Diosgenin Nanocrystals to Improve Oral Bioavailability.
    Liu CZ, Chang JH, Zhang L, Xue HF, Liu XG, Liu P, Fu Q.
    AAPS PharmSciTech; 2017 Aug; 18(6):2067-2076. PubMed ID: 27995466
    [Abstract] [Full Text] [Related]

  • 7. Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol.
    Miao X, Sun C, Jiang T, Zheng L, Wang T, Wang S.
    J Pharm Pharm Sci; 2011 Aug; 14(2):196-214. PubMed ID: 21733409
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability.
    Khan MA, Ansari MM, Arif ST, Raza A, Choi HI, Lim CW, Noh HY, Noh JS, Akram S, Nawaz HA, Ammad M, Alamro AA, Alghamdi AA, Kim JK, Zeb A.
    Drug Deliv; 2021 Dec; 28(1):2510-2524. PubMed ID: 34842018
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Formulation, optimization, and in vitro-in vivo evaluation of olmesartan medoxomil nanocrystals.
    Jain S, Patel K, Arora S, Reddy VA, Dora CP.
    Drug Deliv Transl Res; 2017 Apr; 7(2):292-303. PubMed ID: 28116656
    [Abstract] [Full Text] [Related]

  • 14. Preparation and characterization of quercetin nanocrystals.
    Sahoo NG, Kakran M, Shaal LA, Li L, Müller RH, Pal M, Tan LP.
    J Pharm Sci; 2011 Jun; 100(6):2379-90. PubMed ID: 21491450
    [Abstract] [Full Text] [Related]

  • 15. In Vitro and In Vivo Evaluation of Olmesartan Medoxomil Microcrysta ls and Nanocrystals: Preparation, Characterization, and Pharmacokinet ic Comparison in Beagle Dogs.
    Chai R, Gao H, Ma Z, Guo M, Fu Q, Liu H, He Z.
    Curr Drug Deliv; 2019 Jun; 16(6):500-510. PubMed ID: 31244438
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation.
    Jiang T, Han N, Zhao B, Xie Y, Wang S.
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1230-9. PubMed ID: 22229827
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.